Logo 200 Logo 200 (Methylphenidate hydrochloride extended-release 20 mg)
Pill imprint Logo 200 Logo 200 has been identified as Methylphenidate hydrochloride extended-release 20 mg.
Methylphenidate is used in the treatment of adhd; narcolepsy; fatigue; depression; obesity (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- Logo 200 Logo 200
- 20 mg
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Actavis South Atlantic LLC
- National Drug Code (NDC):
- Inactive Ingredients:
hypromellose acetate succinate 12070923 (3 mm2/s)
|NDC Code||Manufacturer / Repackager|
|45963-0200||Actavis Pharma, Inc.|
Note: Inactive ingredients may vary.
More about methylphenidate
- Methylphenidate chewable tablets
- Methylphenidate controlled-release capsules
- Methylphenidate controlled-release tablets
- Methylphenidate extended-release capsules
- More (7) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.